Highlander Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.14M | Sell |
39,350
-250
| -0.6% | -$19.1K | 1.07% | 19 |
|
|
2023
Q4 | $3.13M | Buy |
39,600
+150
| +0.4% | +$10.7K | 1.11% | 16 |
|
|
2023
Q3 | $2.75M | Buy |
39,450
+2,300
| +6% | +$163K | 1.08% | 16 |
|
|
2023
Q2 | $2.57M | Buy |
37,150
+1,000
| +3% | +$71.2K | 1.19% | 15 |
|
|
2023
Q1 | $2.69M | Buy |
36,150
+3,500
| +11% | +$293K | 1.31% | 14 |
|
|
2022
Q4 | $3.04M | Buy |
32,650
+50
| +0.2% | +$4.83K | 1.59% | 9 |
|
|
2022
Q3 | $3.11M | Hold |
32,600
| – | – | 1.79% | 9 |
|
|
2022
Q2 | $3.02M | Sell |
32,600
-2,600
| -7% | -$254K | 1.63% | 12 |
|
|
2022
Q1 | $3.56M | Hold |
35,200
| – | – | 1.67% | 11 |
|
|
2021
Q4 | $3.63M | Sell |
35,200
-875
| -2% | -$80.9K | 1.68% | 11 |
|
|
2021
Q3 | $3.06M | Sell |
36,075
-625
| -2% | -$52.4K | 1.55% | 13 |
|
|
2021
Q2 | $3.06M | Hold |
36,700
| – | – | 1.53% | 13 |
|
|
2021
Q1 | $2.76M | Hold |
36,700
| – | – | 1.44% | 15 |
|
|
2020
Q4 | $2.51M | Sell |
36,700
-1,300
| -3% | -$84.6K | 1.4% | 14 |
|
|
2020
Q3 | $2.22M | Buy |
38,000
+3,100
| +9% | +$193K | 1.34% | 14 |
|
|
2020
Q2 | $2.27M | Sell |
34,900
-9,155
| -21% | -$577K | 1.43% | 13 |
|
|
2020
Q1 | $2.61M | Sell |
44,055
-250
| -0.6% | -$16.7K | 1.88% | 8 |
|
|
2019
Q4 | $3.29M | Sell |
44,305
-250
| -0.6% | -$17.6K | 1.9% | 7 |
|
|
2019
Q3 | $2.81M | Buy |
44,555
+2,300
| +5% | +$136K | 1.73% | 9 |
|
|
2019
Q2 | $2.3M | Buy |
42,255
+11,625
| +38% | +$626K | 1.4% | 11 |
|
|
2019
Q1 | $1.65M | Buy |
30,630
+27,230
| +801% | +$1.68M | 1.02% | 17 |
|
|
2018
Q4 | $223K | Sell |
3,400
-500
| -13% | -$37.3K | 0.15% | 135 |
|
|
2018
Q3 | $307K | Sell |
3,900
-100
| -3% | -$7.15K | 0.17% | 129 |
|
|
2018
Q2 | $257K | Buy |
4,000
+600
| +18% | +$39.5K | 0.14% | 143 |
|
|
2018
Q1 | $207K | Buy |
3,400
+1,350
| +66% | +$96.9K | 0.12% | 170 |
|
|
2017
Q4 | $149K | Hold |
2,050
| – | – | 0.11% | 196 |
|
|
2017
Q3 | $167K | Sell |
2,050
-4,200
| -67% | -$332K | 0.13% | 180 |
|
|
2017
Q2 | $504K | Hold |
6,250
| – | – | 0.4% | 66 |
|
|
2017
Q1 | $491K | Buy |
6,250
+75
| +1% | +$5.99K | 0.4% | 69 |
|
|
2016
Q4 | $487K | Buy |
6,175
+3,775
| +157% | +$305K | 0.42% | 66 |
|
|
2016
Q3 | $214K | Sell |
2,400
-500
| -17% | -$47.2K | 0.19% | 139 |
|
|
2016
Q2 | $278K | Buy |
2,900
+800
| +38% | +$79.7K | 0.25% | 114 |
|
|
2016
Q1 | $218K | Hold |
2,100
| – | – | 0.2% | 130 |
|
|
2015
Q4 | $205K | Buy |
2,100
+1,500
| +250% | +$147K | 0.19% | 141 |
|
|
2015
Q3 | $57K | Buy |
+600
| New | +$63.1K | 0.05% | 333 |
|
Other funds holding CVS
Highlander Capital Management's CVS Position: Q1 2024 in Review
Highlander Capital Management reduced its CVS Health (CVS) stake by 0.63% in Q1 2024, selling an estimated $19.1K and leaving 39,350 shares worth $3.14M. The position accounts for 1.07% of the portfolio, ranked #19.
Highlander Capital Management first reported a position in CVS in Q3 2015 and has held it in 35 quarters since. The position peaked at $3.63M in Q4 2021. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.
- Highlander Capital Management held 39,350 shares of CVS Health worth $3.14M as of Q1 2024.
- Highlander Capital Management sold 250 CVS Health shares in Q1 2024, an estimated $19.1K.
- CVS Health made up 1.07% of Highlander Capital Management's portfolio in Q1 2024, its #19 holding.
- Highlander Capital Management first reported a position in CVS Health in Q3 2015 and has held it in 35 quarters since.
- Highlander Capital Management's CVS Health position peaked at $3.63M in Q4 2021.
- 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.